Monopar Therapeutics stockholders elect six directors, approve say-on-pay and auditor at annual meeting

Monopar Therapeutics

All six director nominees elected with >3.4M votes each (excluding broker non-votes); no contest.
Advisory say-on-pay approved: 4,382,795 for, 2,933 against, 6,840 abstain.
Stockholders vote for annual say-on-pay frequency: 4,383,765 for every year.
Auditor BPM LLP ratified: 5,044,817 for, 2,300 against, 1,277 abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.